探討 microRNAs 在慢性血癌抗藥性機制形成中所扮演的角色

Medicine & Life Sciences

1. MicroRNAs 100%
2. Leukemia, Myelogenous, Chronic, BCR-ABL Positive 87%
3. Drug Resistance 40%
4. Imatinib Mesylate 29%
5. ran GTP-Binding Protein 29%
6. GTPase-Activating Proteins 23%
7. Genes 17%
8. Pharmaceutical Preparations 16%
9. 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide 12%
10. Dasatinib 12%
11. MDR Genes 12%
12. K562 Cells 10%
13. Down-Regulation 6%
14. Nuclear Pore 5%
15. Small Untranslated RNA 5%
16. Gene Expression 5%